Treace Medical Concepts Inc (TMCI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) has a cash flow conversion efficiency ratio of 0.094x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.23 Million) by net assets ($77.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Treace Medical Concepts Inc worth for the company's overall valuation and market capitalisation.
Treace Medical Concepts Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Treace Medical Concepts Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Treace Medical Concepts Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Treace Medical Concepts Inc ranked by their cash flow conversion efficiency. Explore Treace Medical Concepts Inc cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Easy Trip Planners Limited
NSE:EASEMYTRIP
|
-0.020x |
|
Samsung C and T 1P Pref
KO:02826K
|
0.026x |
|
Síminn hf
IC:SIMINN
|
0.082x |
|
Alro Slatina
RO:ALR
|
0.049x |
|
NXG NextGen Infrastructure Income Fund
NYSE:NXG
|
0.768x |
|
Kalyani Investment Company Limited
NSE:KICL
|
-0.001x |
|
Toubani Resources Ltd
AU:TRE
|
-0.052x |
|
Shandong Kehui Power Automation Co Ltd
SHG:688681
|
0.037x |
Annual Cash Flow Conversion Efficiency for Treace Medical Concepts Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Treace Medical Concepts Inc from 2019 to 2025. View Treace Medical Concepts Inc stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $87.33 Million | $-15.97 Million | -0.183x | +44.46% |
| 2024-12-31 | $112.89 Million | $-37.17 Million | -0.329x | -31.35% |
| 2023-12-31 | $137.94 Million | $-34.58 Million | -0.251x | +50.50% |
| 2022-12-31 | $60.53 Million | $-30.65 Million | -0.506x | -174.10% |
| 2021-12-31 | $93.07 Million | $-17.19 Million | -0.185x | +96.81% |
| 2020-12-31 | $776.00K | $-4.49 Million | -5.791x | -138.58% |
| 2019-12-31 | $3.16 Million | $-7.67 Million | -2.427x | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more